Farmacule’s advantage over many other molecular farming companies is that it has exclusive rights to the INPACT technology platform developed by Queensland University of Technology and an expected low cost of production.

INPACT has:

• An ability to turn molecule production on and off at a specific part of the plant, at a specific point in time – either in response to specific external or internal influences
• An ability to amplify gene expression
• An ability to incorporate male sterility traits in plants to prevent the release of modified plant traits into the environment
• Applicability to both monocots and dicots
• Further applications in virus resistance and amplification of mammalian cell expression systems.